Evidence map›Paper›PMID 21861776›Full record

ArticleAIDS research and human retroviruses2012

Functional analysis of HIV type 1 Nef gene variants from adolescent and adult survivors of perinatal infection.

Jun Zuo, Jeffrey Suen, Alanna Wong, Martha Lewis, Ali Ayub, Marvin Belzer, Joseph Church, Otto O Yang, Paul Krogstad

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jun ZuoUCLA AIDS Institute and the David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1752, USA.
Jeffrey Suen
Alanna Wong
Martha Lewis
Ali Ayub
Marvin Belzer
Joseph Church
Otto O Yang
Paul Krogstad
Black AIDS Institute · USChildren's Hospital of Los Angeles · US

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Immune Pressure on HIV-1 Nef by Cytotoxic T LymphocytesR01AI051970 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, OTTO O · 2002 to 2011
$4.1M
HIV Replication and Thymopoiesis in AdolescentsR01AI051996 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KROGSTAD, PAUL A · 2003 to 2007
$3.2M
HIV-1 Nef's Role in Pathogenesis in vivoR01AI083083 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEWIS, MARTHA J · 2009 to 2012
$1.5M
NIAID NIH HHS AI028697NIAID NIH HHS AI051970NIAID NIH HHS AI051996NIAID NIH HHS AI083083
6 · The paper itself

Abstract

Throughout the world, infants and children with HIV-1 infection are increasingly surviving into adolescence and adulthood. As HIV Nef is an important determinant of the pathogenic potential of the virus, we examined nef alleles in a cohort of extreme long-term survivors of HIV infection (average age of 16.6 years) to determine if Nef defects might have contributed to patient survival. HIV nef gene sequences were amplified for phylogenetic analysis from 15 adolescents and adults infected by mother-to-child transmission (n=10) or by blood transfusion (n=5). Functional analysis was performed by inserting patient-derived nef sequences into an HIV-derived vector that permits simultaneous evaluation of the impact of the Nef protein on MHC-I and CD4 cell surface expression. We found evidence of extensive nef gene diversity, including changes in known functional domains involved in the downregulation of cell surface MHC-I and CD4. Only 3 of 15 individuals (20%) had nef alleles with a loss of the ability to downregulate either CD4 or MHC-I. Survival into adulthood with HIV infection acquired in infancy is not uniformly linked to loss of function in nef. The Nef protein remains a potential target for immunization or pharmacologic intervention.

Indexed as

AdolescentCD4-Positive T-LymphocytesCohort StudiesDown-RegulationFemaleGenetic VariationHIV-1HIV Long-Term SurvivorsHIV SeropositivityHumansInfectious Disease Transmission, VerticalLos AngelesMalenef Gene Products, Human Immunodeficiency VirusPhylogenyYoung Adultnef Gene Products, Human Immunodeficiency Virus

Identifiers

PMID21861776
PMCPMC3332374
OpenAlexW2076081583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.